These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4467727)

  • 1. Naloxone in the treatment of the young heroin abuser.
    Pierson PS; Rapkin RM; Kleber HD
    Am J Drug Alcohol Abuse; 1974; 1(2):243-52. PubMed ID: 4467727
    [No Abstract]   [Full Text] [Related]  

  • 2. Narcotic antagonist treatment of addict parolees--the failure of an effective approach.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Compr Psychiatry; 1977; 18(3):211-9. PubMed ID: 858238
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
    Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
    Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
    [No Abstract]   [Full Text] [Related]  

  • 4. Contingent naloxone (N-allylnoroxymorphone) treatment of the paroled narcotic addict.
    Kurland AA; McCabe L; Hanlon TE
    Int Pharmacopsychiatry; 1975; 10(3):157-68. PubMed ID: 1099047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
    Caruso FS; Gordon M; Pachter IJ
    Proc Natl Conf Methadone Treat; 1973; 2():1336-41. PubMed ID: 4215978
    [No Abstract]   [Full Text] [Related]  

  • 6. Methadone-naloxone in combination for the treatment of heroin addicts.
    Parwatikar SD; Knowles RR
    Clin Pharmacol Ther; 1973; 14(6):941-8. PubMed ID: 4584151
    [No Abstract]   [Full Text] [Related]  

  • 7. Naloxone-methadone combination for the treatment of opiate dependence.
    Parwatikar S; Knowles RR
    Proc Natl Conf Methadone Treat; 1973; 2():1350-4. PubMed ID: 4612373
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
    Amass L; Pukeleviciene V; Subata E; Almeida AR; Pieri MC; D'Egidio P; Stankova Z; Costa A; Smyth BP; Sakoman S; Wei Y; Strang J
    Addiction; 2012 Jan; 107(1):142-51. PubMed ID: 21749526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies with naloxone/methadone in a ratio of 1:20.
    Bloom WA; Sudderth EW; Marcello L
    Proc Natl Conf Methadone Treat; 1973; 2():1342-9. PubMed ID: 4612372
    [No Abstract]   [Full Text] [Related]  

  • 10. [A possibility of the use of low naloxone dosages in the treatment of heroin dependence].
    Nadezhdin AV; Litvinova SV; Tetenova EIu; Mikhalev IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):56-7. PubMed ID: 16457136
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.
    Cantwell K; Dietze P; Flander L
    Resuscitation; 2005 Jun; 65(3):315-9. PubMed ID: 15919568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia.
    Lenton SR; Dietze PM; Degenhardt L; Darke S; Butler TG
    Drug Alcohol Rev; 2009 Nov; 28(6):583-5. PubMed ID: 19930009
    [No Abstract]   [Full Text] [Related]  

  • 14. Methadone-naloxone mixtures for use in methadone maintenance programs. I. An evaluation in man of their pharmacological feasibility. II. Demonstration of acute physical dependence.
    Nutt JG; Jasinski DR
    Clin Pharmacol Ther; 1974 Feb; 15(2):156-66. PubMed ID: 4812153
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport.
    Vilke GM; Sloane C; Smith AM; Chan TC
    Acad Emerg Med; 2003 Aug; 10(8):893-6. PubMed ID: 12896894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experiences with narcotic antagonists: cyclazocine and naloxone.
    Proc Natl Conf Methadone Treat; 1973; 1():447-51. PubMed ID: 4808183
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy in overdose and withdrawal syndrome in heroin addicts].
    Arrizabalaga Cuesta C; Zulaica D
    Rev Enferm; 1985 Feb; 8(78):23-5. PubMed ID: 3845677
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription naloxone: a novel approach to heroin overdose prevention.
    Sporer KA; Kral AH
    Ann Emerg Med; 2007 Feb; 49(2):172-7. PubMed ID: 17141138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone hazard in drug abuser.
    Popper C; Kelen GD; Cunningham G
    Lancet; 1989 Aug; 2(8660):446. PubMed ID: 2569624
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological adjuncts in the treatment of opiate dependence.
    Resnick RB
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.